CompletedNCT01582945
Ketamine Added to Antidepressants for Treatment-Resistant Depression
About this title
Read the official source — NCT01582945Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
What did participation involve?
The study group receives ketamine as a study medication.
- Listed locations
- BostonSee all locations and recruitment
Study information
Study start dateApril 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01582945
- Official title
Show the full official title
N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including ketamine.
Who was this study for?
Listed age limits: 18 years to 65 years.
